Sun Pharmaceutical Industries has entered into an agreement with US based Pharmazz Inc., pursuant to which Sun Pharma has agreed to invest up to $25 milion in Pharmazz Inc. The investment triggers conversion of earlier investment through Simple Agreement for Future Equity (SAFE) resulting in aggregate stake of up to around 22.7% in Pharmazz on fully diluted basis.
The first tranche of $10 million, along with the balance of $7.5 million out of SAFE tranche 2 investment, will be invested on or before May 31, 2025. The second tranche of $15 million will be invested on or before November 30, 2025 or such other mutually agreed date.
Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1670.40 |
| Dr. Reddys Lab | 1236.50 |
| Cipla | 1234.30 |
| Zydus Lifesciences | 942.40 |
| Lupin | 2332.80 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: